[HTML][HTML] The amyloid-β oligomer hypothesis: beginning of the third decade

EN Cline, MA Bicca, KL Viola… - Journal of Alzheimer's …, 2018 - content.iospress.com
The amyloid-β oligomer (AβO) hypothesis was introduced in 1998. It proposed that the brain
damage leading to Alzheimer's disease (AD) was instigated by soluble, ligand-like AβOs …

[HTML][HTML] Activation and role of astrocytes in ischemic stroke

XY Shen, ZK Gao, Y Han, M Yuan, YS Guo… - Frontiers in cellular …, 2021 - frontiersin.org
Ischemic stroke refers to the disorder of blood supply of local brain tissue caused by various
reasons. It has high morbidity and mortality worldwide. Astrocytes are the most abundant …

Safety, efficacy, and feasibility of intranasal insulin for the treatment of mild cognitive impairment and Alzheimer disease dementia: a randomized clinical trial

S Craft, R Raman, TW Chow, MS Rafii, CK Sun… - JAMA …, 2020 - jamanetwork.com
Importance Insulin modulates aspects of brain function relevant to Alzheimer disease and
can be delivered to the brain using intranasal devices. To date, the use of intranasal insulin …

[HTML][HTML] Protective functions of reactive astrocytes following central nervous system insult

M Linnerbauer, V Rothhammer - Frontiers in immunology, 2020 - frontiersin.org
Astrocytes play important roles in numerous central nervous system disorders including
autoimmune inflammatory, hypoxic, and degenerative diseases such as Multiple Sclerosis …

[HTML][HTML] Brain insulin resistance and hippocampal plasticity: mechanisms and biomarkers of cognitive decline

M Spinelli, S Fusco, C Grassi - Frontiers in neuroscience, 2019 - frontiersin.org
In the last decade, much attention has been devoted to the effects of nutrient-related signals
on brain development and cognitive functions. A turning point was the discovery that brain …

[HTML][HTML] Dual roles of astrocyte-derived factors in regulation of blood-brain barrier function after brain damage

S Michinaga, Y Koyama - International journal of molecular sciences, 2019 - mdpi.com
The blood-brain barrier (BBB) is a major functional barrier in the central nervous system
(CNS), and inhibits the extravasation of intravascular contents and transports various …

[HTML][HTML] Metabolic syndrome as a risk factor for Alzheimer's disease: a focus on insulin resistance

A Ezkurdia, MJ Ramírez, M Solas - International Journal of Molecular …, 2023 - mdpi.com
Alzheimer's disease (AD) is the main type of dementia and is a disease with a profound
socioeconomic burden due to the lack of effective treatment. In addition to genetics and …

[HTML][HTML] Insulin resistance in Alzheimer's disease

LSS Ferreira, CS Fernandes, MNN Vieira… - Frontiers in …, 2018 - frontiersin.org
The epidemiological connection between diabetes, obesity, and dementia represents an
important public health challenge but also an opportunity to further understand these …

Nanomaterials for the treatment and diagnosis of Alzheimer's disease: an overview

M Bilal, M Barani, F Sabir, A Rahdar, GZ Kyzas - NanoImpact, 2020 - Elsevier
Alzheimer's disease (AD) is a chronic neurodegenerative disorder associated with
dementia. To overcome the limitations of diagnosis and treatment nanotechnology research …

[HTML][HTML] Nanocarriers as a powerful vehicle to overcome blood-brain barrier in treating neurodegenerative diseases: Focus on recent advances

X Niu, J Chen, J Gao - Asian journal of pharmaceutical sciences, 2019 - Elsevier
Neurodegenerative diseases including Alzheimer's disease, Parkinson's disease,
Huntington disease and amyotrophic lateral sclerosis throw a heavy burden on families and …